Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M van Rossum

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The American Journal of Gastroenterology|December 12, 2007
Proton pump inhibitors and the risk of colorectal cancerEva M van Soest, Leo G M van Rossum, Jeanne P Dieleman, et al.
Journal of Public Health (Oxford, England)|August 22, 2008
Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood testA F van Rijn, L G M van Rossum, M Deutekom, et al.
Journal of Medical Screening|October 18, 2008
Getting adequate information across to colorectal cancer screening subjects can be difficultA F van Rijn, L G M van Rossum, M Deutekom, et al.
Scandinavian Journal of Gastroenterology|June 22, 2010
Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspectiveMarije Deutekom, Leo G M van Rossum, Anne F van Rijn, et al.
Family Practice|May 7, 2004
Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care settingR J F Laheij, J Th Hermsen, J B M J Jansen, et al.
The Netherlands Journal of Medicine|March 7, 2006
Gastrointestinal disorders and symptoms: does body mass index matter?M G H van Oijen, D F G M Josemanders, R J F Laheij, et al.
International Journal of Cancer|September 9, 2010
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paperMichael J Duffy, Leo G M van Rossum, Sietze T van Turenhout, et al.
International Journal of Cancer|May 2, 2009
False negative fecal occult blood tests due to delayed sample return in colorectal cancer screeningLeo G M van Rossum, Anne F van Rijn, Martijn G H van Oijen, et al.
British Journal of Cancer|September 17, 2009
Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programmeL G M van Rossum, A F van Rijn, R J F Laheij, et al.
Digestion|November 8, 2007
Open-access upper gastrointestinal endoscopy a decade after the introduction of proton pump inhibitors and helicobacter pylori eradication: a shift in endoscopic findingsLieke A S van Kerkhoven, Sally J van Rijswijck, Leo G M van Rossum, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The American Journal of Gastroenterology|December 12, 2007
Proton pump inhibitors and the risk of colorectal cancerEva M van Soest, Leo G M van Rossum, Jeanne P Dieleman, et al.
Journal of Public Health (Oxford, England)|August 22, 2008
Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood testA F van Rijn, L G M van Rossum, M Deutekom, et al.
Journal of Medical Screening|October 18, 2008
Getting adequate information across to colorectal cancer screening subjects can be difficultA F van Rijn, L G M van Rossum, M Deutekom, et al.
Scandinavian Journal of Gastroenterology|June 22, 2010
Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspectiveMarije Deutekom, Leo G M van Rossum, Anne F van Rijn, et al.
Family Practice|May 7, 2004
Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care settingR J F Laheij, J Th Hermsen, J B M J Jansen, et al.
The Netherlands Journal of Medicine|March 7, 2006
Gastrointestinal disorders and symptoms: does body mass index matter?M G H van Oijen, D F G M Josemanders, R J F Laheij, et al.
International Journal of Cancer|September 9, 2010
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paperMichael J Duffy, Leo G M van Rossum, Sietze T van Turenhout, et al.
International Journal of Cancer|May 2, 2009
False negative fecal occult blood tests due to delayed sample return in colorectal cancer screeningLeo G M van Rossum, Anne F van Rijn, Martijn G H van Oijen, et al.
British Journal of Cancer|September 17, 2009
Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programmeL G M van Rossum, A F van Rijn, R J F Laheij, et al.
Digestion|November 8, 2007
Open-access upper gastrointestinal endoscopy a decade after the introduction of proton pump inhibitors and helicobacter pylori eradication: a shift in endoscopic findingsLieke A S van Kerkhoven, Sally J van Rijswijck, Leo G M van Rossum, et al.
Pageof 8